Prevention and Treatment of Osteoporosis in Postmenopausal Women: Defining the Role of Alendronate

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.12, Iss.1, 2004-01, pp. : 19-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Postmenopausal Osteoporosis: Defining the Role of Raloxifene

By Wellington K. Plosker G.L.

Disease Management & Health Outcomes, Vol. 11, Iss. 10, 2003-01 ,pp. : 673-692

Adis International

Access to resources Recommend Favorite

Single annual injectable treatment for postmenopausal osteoporosis

By Chapurlat Roland D

Expert Opinion on Drug Delivery, Vol. 5, Iss. 5, 2008-05 ,pp. : 583-591

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis

By Mueller Dirk

Applied Health Economics and Health Policy, Vol. 9, Iss. 4, 2011-07 ,pp. : 259-273

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ultrasound and Bone Densitometry for Osteoporosis Screening in Post-Menopausal Women

By Mueller Dirk Gandjour Afschin

Applied Health Economics and Health Policy, Vol. 6, Iss. 2-3, 2008-01 ,pp. : 113-135

Adis International

Access to resources Recommend Favorite

Management of Hormone-Responsive Postmenopausal Breast Cancer: Defining the Role of Anastrozole

By Wiseman Lynda R. Scott Lesley J.

Disease Management & Health Outcomes, Vol. 13, Iss. 5, 2005-01 ,pp. : 337-354

Adis International

Access to resources Recommend Favorite